Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Saskatoon, Saskatchewan--(Newsfile Corp. - September 4, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") today announced the appointment of Tyler Reinheimer, CPA, as Director, Finance of the Company and that the board of directors of the Company has authorized and approved the grant of a total of 1,126,954 deferred share units of the Company ("DSUs") to directors (excluding the Company's Chief Excutive Officer and Chief Operating Officer) and Mr. Reinheimer, effective September 3, 2026.

MustGrow Biologics Corp. (MGRO:CA) Q2 2026 Earnings Call Transcript

Investor Webcast: Monday, August 31 st at 4:00pm ET / 1:00pm PT Register/View Here: https://us02web.zoom.us/webinar/register/1317861230560/WN_oKTSGbCQR1KjX5MnyGC3kw#/registration Please join/register at least 5 minutes prior to the call. Email questions to [email protected] before 2:00pm ET, which will be addressed during the Q&A portion of the webcast.

Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Market One ("Market One"), a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors. Market One delivers content creation and distribution through a suite of products across video, editorial, and social media.

Bayer AG has paid MustGrow the first development milestone payment. The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow's mustard-based biocontrol technologies in Europe, Middle East and Africa.